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Layer- and subregion-specific 
electrophysiological and 
morphological changes of the 
medial prefrontal cortex in a mouse 
model of neuropathic pain
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Francesco Ferraguti  2, Kai K. Kummer 1 & Michaela Kress1
Chronic neuropathic pain constitutes a serious public health problem, but the disease mechanisms 
are only partially understood. The involvement of different brain regions like the medial prefrontal 
cortex has already been established, but the comparison of the role of different subregions and layers 
is still inconclusive. In the current study, we performed patch-clamp recordings followed by anatomical 
reconstruction of pyramidal cells from different layers of the prelimbic and infralimbic subregions of the 
medial prefrontal cortex in neuropathic (spared nerve injury, sNI) and control mice. We found that in 
the prelimbic cortex, layer 2/3 pyramidal cells from SNI mice exhibited increased excitability compared 
to sham controls, whereas prelimbic layer 5 pyramidal neurons showed reduced excitability. Pyramidal 
cells in both layer 2/3 and layer 5 of the infralimbic subregion did not change their excitability, but 
layer 2/3 pyramidal cells displayed increased dendritic length and branching. Our findings support the 
view that chronic pain is associated with subregion- and layer-specific changes in the medial prefrontal 
cortex. They therefore provide new insights into the mechanisms underlying the chronification of pain.
Chronic neuropathic pain constitutes a serious public health problem that affects a large number of individuals 
worldwide1–4. The disease mechanisms underlying the chronification of pain are still not completely understood, 
as is its connection with frequently occurring cognitive and affective impairments5,6. Only a decade ago, research 
has started to systematically investigate pain related changes of neuronal processing at supraspinal levels, includ-
ing the brainstem, as well as subcortical and cortical brain regions (for review see7 and8). The medial prefrontal 
cortex (mPFC), which is primarily known for its prominent role in attention and goal-directed behavior9, pro-
vides top-down regulation of sensory and affective processes10, including inhibition of both sensory and affective 
nociceptive signals by descending projections to various brain and spinal cord regions11–13. In both human sub-
jects and rodent models, the mPFC undergoes structural as well as functional changes in chronic pain states14–21, 
which are reflected by cognitive deficits and decreased attention (for review see22). In line with this, attention 
directed to painful stimuli increases reported pain intensities23 and attention distraction reduces subjective pain 
intensities in human healthy volunteers24,25, thereby suggesting a strong impact of attention on the chronification 
of pain.
From an anatomical as well as functional perspective and based on their projection targets, the mPFC can be 
subdivided into the anterior cingulate cortex (ACC), the prelimbic (PrL) and the infralimbic cortex (IL)26. The 
ACC extends rostro-caudally, shows increased activity during acute pain perception as well as during persistent 
pain conditions27,28, and reduction of ACC activity has been found to relieve pain29. For the remaining mPFC 
subregions, the majority of studies have so far not separated IL and PrL contributions to functional and structural 
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changes in pain processing15,30–32. Also, effects of chronic pain on neuronal populations of different layers of these 
regions have not yet been investigated systematically.
The current study is therefore the first to systematically dissect the effects of persistent nociceptive activity 
from the spared nerve injury model of neuropathic pain on pyramidal neurons of layers 2/3 and layer 5 in the PrL 
and IL mPFC subregions, providing evidence for subregion- and layer-specific alterations of electrophysiological 
properties and dendritic complexity.
Methods
Animals. All procedures involving animals were carried out in accordance with the Ethics Guidelines of 
Animal Care (Medical University of Innsbruck), as well as the European Communities Council Directive of 22 
September 2010 on the protection of animals used for scientific purposes (2010/63/EU), and approved by the 
Austrian National Animal Experiment Ethics Committee of the Austrian Bundesministerium für Wissenschaft 
und Forschung (permit number BMWF-66.011/0087-WF/V/3b/2016). C57BL/6 J mice (Janvier Labs) were 
housed under specific pathogen-free (SPF) conditions. Animals were maintained at constant room temperature 
of 24 °C on a 12 h light/dark cycle with lights on from 07:00 to 19:00 and had ad libitum access to autoclaved pel-
leted food and water. A total of nineteen male adult mice (8–10 weeks old) were used for the experiments. The 
animals were individually housed for at least 7 days before surgery.
spared nerve injury (sNI). Mice were subjected to SNI as an animal model of persistent peripheral neu-
ropathic pain according to the method of33. Animals were anesthetized with a mixture of ketamine (Ketasol®, 
20 mg/ml) and xylazine (Xylasol®, 2 mg/ml) in PBS (5 µl/g body weight, i.p). The sciatic nerve of the left hind leg 
was exposed at the level of the trifurcation into the sural, tibial, and common peroneal nerves. The tibial and com-
mon peroneal nerves were tightly ligated and transected 1–2 mm distal to the ligation, leaving the sural branch 
intact. Sham-operated mice without nerve transection served as controls as their sciatic nerves were exposed 
without additional manipulations. The successful induction of mechanical allodynia was confirmed using a 
dynamic plantar aesthesiometer (Ugo Basile; Supplemental Fig. 1).
Dynamic plantar test. In order to assess hind paw mechanical sensitivity, mice were habituated to a 
plexi-glass chamber with a metal wire mesh floor for 15 min. The mechanical stimulus was delivered perpendicu-
larly to the lateral side of the plantar surface of the paw (sural nerve innervation territory) by an automated testing 
device (Dynamic Plantar Aesthesiometer, Ugo Basile). A 0.5 mm steel rod was pushed against the hind paw with 
ascending force of 0 to 10 g over a period of 10 s at a rate of 1 g/s. The mechanical stimulus automatically stopped 
when the animal withdrew its hind paw, and the threshold was calculated as an average of three consecutive trials 
in both paws.
Acute brain slice preparation. Acute coronal brain slices were prepared as previously described34. Briefly, 
7 days after surgery the animals were anesthetized with isoflurane (Forane®, AbbVie) and decapitated. Brains 
were rapidly removed and immersed in ice-cold oxygenated protective artificial cerebrospinal fluid (aCSF, 
95% O2, 5% CO2) containing (in mM): N-methyl-D-glucamine 110, HCl 110, KCl 2.5, NaH2PO4 1.2, NaHCO3 
25, D-glucose 25, MgSO4 10, CaCl2 0.5, Na-ascorbate 1 and Na-pyruvate 2.9, osmolarity: ~310 mOsm/kg, pH 
adjusted to 7.4 with HCl35. The brains were trimmed with a scalpel blade and glued onto the stage of a vibrating 
microtome (VT1200S, Leica Microsystems). Coronal slices (thickness 300 µm) containing both the prelimbic 
and the infralimbic subregions of the prefrontal cortex were cut in oxygenated ice-cold protective aCSF and sub-
sequently incubated at 32–34 °C for 5 minutes. After this recovery period, the slices were transferred to standard 
oxygenated aCSF containing (in mM): NaCl 125, NaHCO3 25, D-glucose 25, KCl 2.5, NaH2PO4 1.25, CaCl2 2 and 
MgCl2 1, osmolarity: ~310 mOsm/kg, pH adjusted to 7.4 with HCl36 at room temperature for at least 30 minutes 
before the electrophysiological recordings.
electrophysiological recordings and analysis. Sections were visualized in a recording chamber of an 
upright microscope (BX51WI, Olympus) equipped with differential infrared contrast optics (DIC), and con-
tinuously perfused with oxygenated standard aCSF (2–3 ml/min). Synaptic transmission was blocked using 
CNQX (6-cyano-7-nitroquinoxaline-2,3-dione, 5 μM), picrotoxin (5 μM) and D-AP5 (5 μM). Patch pipettes 
were pulled from borosilicate glass capillaries (Science Products) using a flaming micropipette puller (P97, Sutter 
Instruments) resulting in a pipette resistance of 3–6 MΩ after filling. The pipette solution for current-clamp 
recordings contained (in mM): 135 K-gluconate, 20 KCl, 2 MgCl2, 10 HEPES, 0.1 EGTA, 2 Mg-ATP, 0.3 Na-GTP 
and 3–5 mg/ml biocytin (osmolarity: ~295 mOsm/kg, pH adjusted to 7.3 with KOH). Recordings were performed 
at room temperature with an EPC 10 amplifier and PatchMaster software v2x73.1 (HEKA). Data were filtered at 
2.9 kHz using a Bessel filter, and the sampling rate ranged from 20 to 50 kHz depending on the protocol applied. 
Access resistance (Rs) was monitored in the voltage-clamp configuration by analysing capacitive transients during 
10 ms square wave depolarizing pulses. Recordings were included only when a GΩ seal formed prior to whole-cell 
access with a Rs of less than 20 MΩ.
Whole-cell patch clamp recordings were obtained from pyramidal cells in layers 2/3 and layer 5 depending on 
their perpendicular distance from the midline, 100–300 µm and 300–500 µm, respectively. One coronal slice was 
used per animal and chosen according to the coordinates from37, relative to Bregma, in mm: AP +1.70. Prelimbic 
and infralimbic subregions were targeted based on their vertical distance from the dorsal end of the midline, 
600–1300 µm and 1450–1900 µm, respectively. Data acquisition started 10 min after entering the whole-cell mode 
allowing sufficient stabilization of the recording. Pyramidal neurons from different layers and subregions were 
recorded in each of the slices and were distinguished from interneurons by their shape, spiking pattern and action 
potential width38. In addition, their identity was confirmed by their large apical dendrites, which were visualized 
through immunohistochemical processing.
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None of the neurons showed spontaneous activity, and all parameters were obtained at resting membrane 
potential (RMP) that was determined by averaging a 1 min recording period at 0 pA in current clamp mode 
(Supplemental Fig. 2; Supplemental Table 1). Depolarizing current steps (50 ms) with an increment of 10 pA were 
applied every 3 s via the recording electrode until an action potential (AP) was elicited. Action potential thresh-
old current (IAP) was defined as the minimum amount of current needed to induce the first AP. AP analysis was 
performed as described previously39. Briefly, five consecutive APs induced by a 50 ms IAP +10 pA depolarizing 
current were averaged and analyzed using the FitMaster software (HEKA). AP amplitude, afterhyperpolarization 
(AHP) and AHP time to peak (tAHP) were determined relative to the AP threshold. AP duration was determined 
at its half-amplitude as AP half-width. The first derivative was used to extract the maximum speed of depolariza-
tion (dv/dtmax) and repolarization (dv/dtmin). AP threshold voltage was taken at the point where the depolariza-
tion speed first exceeded 10 mV/ms.
Additional biophysical parameters were extracted from voltage responses to 500 ms current pulses at 0.2 Hz 
ranging from −100 to +500 pA in 20 pA increments. Input resistance (Rin) was obtained by linear fit of the I/V 
curve from −100 to 0 pA. Membrane time constant (τm) and membrane capacitance (Cm) were obtained by an 
exponential fit to the voltage response following a −40 mV hyperpolarizing step current40. AP latency of the 1st 
AP was measured as time from current onset to crossing the voltage threshold of 0 mV. Input-Frequency (I-F) 
slope was calculated as linear coefficient of the 2nd order polynomial fit of the AP frequency vs. current injection 
relation. Mean inter-spike interval (ISI) and adaptation ratio (1st ISI/9th ISI) were taken from the first trace with 
at least 10 APs. Sag ratio (%) was calculated from the current injection that would cause a hyperpolarization of 
approximately −7.5 mV38 as (Vss − Vmin)/(Vmin − Vrmp), with Vmin being the minimum value reached after the 
beginning of the current injection, Vss being the voltage at steady-state and Vrmp being the resting membrane 
potential. After experiments were completed, slices were immersed in a 4% paraformaldehyde (PFA) fixative for 
at least 24 h prior to subsequent visualization of the filled neurons.
Biocytin visualization. Neuronal morphology was assessed using a diaminobenzidine (DAB; 
Sigma-Aldrich) staining protocol as follows: slices were washed three times in Tris-buffered saline (TBS; 0.9% 
NaCl, 0.05 M Tris, pH 7.4) for 10 min each. Subsequently, slices were left for overnight incubation in a 1:100 
solution of avidin-biotinylated horseradish peroxidase (ABC-Elite) in 1% Bovine Serum Albumin (BSA)-TBS at 
4 °C. On the next day, sections were washed in TBS and Tris buffer (TB; 0.05 M Tris, pH 7.4), before incubating 
them in 0.5 mg/ml DAB in TB with Nickel (4 mg/ml). Hydrogen peroxide (0.003%) was added to TB in order to 
start the peroxidase reaction. Sections were then rinsed with TBS three times and mounted on gelatin-coated 
slides, and left to air-dry. Finally, they were dehydrated and coverslipped using Eukitt (Marienfeld Lab. Glassware, 
Germany).
3D reconstruction and Sholl analysis. Biocytin-stained neurons were 3D reconstructed using the 
NEUROLUCIDA® software (MBF Bioscience). All cells included in the analysis were checked for optimal filling 
in both apical and basal dendrites. Before tracing, cells were visually inspected and discarded if proximal branches 
of the dendrites appeared cut. Somata, dendrites and axonal branches were drawn with a 1.3 NA 100x oil objec-
tive lens (Olympus BX51). Morphological parameters were analyzed with NEUROEXPLORER® software (MBF 
Bioscience), including complexity, somatic area, total dendritic length and branching of the dendrites. The area of 
the cell body was calculated by referring to the boundary of the cell body within a 2D area. To analyze the branch 
order, the centrifugal ordering system was used as it provides information about both the topological distance as 
well the amount of branching within a tree. For each neuron, tracing was performed by following the dendrites 
from the soma to the periphery. Total dendritic length was calculated as the sum of the length of all the branches 
within a dendritic tree, whereas the mean length was obtained by dividing the total length by the number of pri-
mary branches. The complexity was calculated as follows: Complexity = (sum of the terminal orders + number of 
terminals) * (total dendritic length/number of primary dendrites).
In order to determine dendritic complexity in more detail, Sholl analysis was performed using the 
NEUROEXPLORER® software. Concentric Sholl rings were set at 10 µm intervals from the soma. The analysis 
was based on calculating the number of intersections and dendritic length per Sholl ring interval.
statistical analysis. For statistical analyses, GraphPad Prism 7 (two-tailed Student’s t-test, 2-way ANOVA 
followed by Sidak’s multiple comparisons test) and Origin 9 (polynomial curve fitting), were used as applicable. 
The level of statistical significance was predefined at p < 0.05.
Results
As a first step, we confirmed SNI induced mechanical hypersensitivity in the operated paw by measuring 
mechanical withdrawal thresholds at baseline and 7 days after surgery. As expected, SNI operated mice exhib-
ited a significant reduction in the paw withdrawal threshold of the operated paw compared to sham controls as 
well as compared to baseline measurements (2-way RM ANOVA, p < 0.001; Supplemental Fig. 1). In addition, 
the withdrawal threshold of the non-operated (contralateral) paw was unaltered (2-way RM ANOVA, p > 0.05; 
Supplemental Fig. 1).
In order to investigate whether the spared nerve injury (SNI) mouse model induces layer specific and subre-
gion specific electrophysiological and morphological changes in pyramidal cells of the medial prefrontal cortex 
(mPFC), we performed whole-cell patch clamp recordings and subsequent morphological analyses in a subset of 
recorded neurons 7 days after surgery. The prelimbic (PrL) cortex is set along the midline and is bordered dorsally 
by the anterior cingulate cortex and ventrally by the infralimbic (IL) cortex. In this study we investigated layer 2/3 
and layer 5 pyramidal cells of both PrL and IL cortical areas.
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Recordings were performed in the presence of blockers of fast synaptic transmission (5 µM CNQX, 5 µM 
D-AP5, 5 µM picrotoxin) and were included in the analysis only if the resting membrane potential was stable and 
below −60 mV, and if pyramidal cell like morphology was confirmed. Experimenters were blind to the treatment 
condition.
SNI increases the excitability of layer 2/3 pyramidal cells of the prelimbic (PrL) cortex. In order 
to investigate the main input region of the prelimbic (PrL) prefrontal cortex, we first targeted PrL layer 2/3 (L2/3) 
pyramidal cells of sham and SNI treated mice by mapping the landmarks of the coronal slices to the mouse 
brain stereotaxic atlas (37; Fig. 1a). By measuring the distance from the dorsal end of the midline, we ensured 
the same localization of recorded neurons between the two treatment groups (Table 1; x/y coordinates: sham 
917.64 ± 28.98/222.14 ± 5.27 µm vs. SNI 912.33 ± 24.81/230.87 ± 6.89 µm; Student’s t-test, px = 0.89/py = 0.33). 
Whole-cell recordings showed that passive membrane properties of PrL L2/3 pyramidal neurons differed between 
SNI and sham-operated mice (Fig. 1d; Table 1). By measuring the resting membrane potential, we observed a 
more depolarized state of L2/3 pyramidal neurons after SNI, but not sham treatment (SNI −74.37 ± 0.99 mV vs. 
Figure 1. Firing rate and Sholl analysis of layer 2/3 pyramidal cells in the prelimbic (PrL) cortex of SNI and 
sham mice. (a) Location of recorded neurons in the hemisphere contralateral to the injured paw. Recordings 
were performed in the presence of blockers of fast synaptic transmission (5 µM CNQX, 5 µM D-AP5 and 
5 µM picrotoxin). Inset shows DAB stained, biocytin filled neurons in the targeted region. (b) Representative 
examples of reconstructed L2/3 PrL pyramidal cells. (c) Representative electrophysiological profile of L2/3 PrL 
pyramidal neurons in the SNI (left) and sham (right) group. Top, firing pattern when a minimum of 10 action 
potentials was elicited in response to the corresponding current step. Below, adaptation ratios from 1st to the 
n-1st interspike interval relative to the last (nth) presented as a heat map. Bottom, response to hyperpolarizing 
current injections that would be used to calculate the input resistance and the voltage sag ratio. (d) Column 
graphs showing the resting membrane potential and input resistance of the two groups (*p < 0.05, Student’s 
t-test). (e) Firing rate as a function of injected current in SNI mice compared to sham controls (p > 0.05, 2-way 
ANOVA with repeated measures). Input-frequency slope calculated as a linear coefficient of the polynomial 
fitting of the curves (p > 0.05, Student’s t-test). (f) Sholl analysis of the reconstructed apical dendrites in SNI and 
sham treated mice (p > 0.05, 2-way ANOVA). (g) Sholl analysis of the basal dendrites shows an increase in the 
number of intersections and length per distance from soma in SNI mice (p < 0.05, 2-way ANOVA).
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sham −77.08 ± 0.80 mV; Student’s t test, p = 0.04). Neurons from SNI mice showed a higher input resistance (SNI: 
182.44 ± 16.07 MΩ; sham: 140.96 ± 10.32 MΩ) compared to the sham group (Student’s t-test, p = 0.04). The mem-
brane time constant (τm) was also significantly higher in SNI mice compared to sham (SNI 29.14 ± 2.52 ms vs. 
sham 22.33 ± 1.56 ms; Student’s t-test, p = 0.03). Correspondingly, we observed a trend towards increased firing 
rate in response to 500 ms depolarizing current injection in the SNI group (Fig. 1e; Table 1; I-F slope (pA/100 Hz): 
SNI 13.94 ± 0.64 vs. sham 12.45 ± 0.52; Student’s t-test, p = 0.08). AP properties were similar for both groups 
Electrophysiology sham (n = 28) SNI (n = 31) P value Morphology sham (n = 10) SNI (n = 10) P value
RMP (mV) −77.08 ± 0.81 −74.37 ± 1.01 *0.0430 Cell body
Input resistance (MΩ) 140.96 ± 10.51 182.44 ± 16.34 *0.0415 x (µm) 917.64 ± 29.51 912.33 ± 25.24 0.8911
Membrane capacitance (pF) 171.89 ± 10.41 165.37 ± 8.26 0.6222 y (µm) 222.14 ± 5.37 230.87 ± 7.01 0.3322
τm (ms) 22.33 ± 1.59 29.14 ± 2.56 *0.0316 Area (µm²) 120.98 ± 10.17 102.10 ± 6.56 0.1361
Sag ratio (%) 4.55 ± 0.26 4.27 ± 0.28 0.4753 Basal dendrites
Current threshold (pA) 214.29 ± 16.50 176.77 ± 15.67 0.1048 Number 3.80 ± 0.42 5.00 ± 0.47 0.0725
Voltage threshold (mV) −39.06 ± 0.38 −40.09 ± 0.60 0.1656 Nodes 7.10 ± 0.99 7.00 ± 0.67 0.9343
AP amplitude (mV) 57.14 ± 0.54 58.12 ± 0.48 0.1803 Ends 11.20 ± 1.24 12.10 ± 1.06 0.5872
dv/dtmax (mV/ms) 430.38 ± 19.01 459.79 ± 17.55 0.2597 Total length (µm) 672.96 ± 94.98 899.66 ± 104.99 0.1267
dv/dtmin (mV/ms) −56.38 ± 1.87 −60.39 ± 1.86 0.1350 Mean length (µm) 183.02 ± 21.14 181.54 ± 18.09 0.9584
AHP (mV) −46.89 ± 0.51 −47.82 ± 0.42 0.1617 Complexity 6813.75 ± 1629.88 6031.35 ± 919.15 0.6808
AHP time to peak (ms) 4.99 ± 0.14 4.98 ± 0.13 0.9691 Apical dendrite
50% AP width (ms) 1.33 ± 0.04 1.27 ± 0.04 0.2444 Nodes 12.00 ± 1.26 11.10 ± 2.13 0.7198
I-F slope (Hz/100pA) 12.45 ± 0.53 13.94 ± 0.66 0.0859 Ends 13.00 ± 1.26 12.30 ± 2.17 0.7833
1st AP latency (ms) 167.99 ± 8.30 179.67 ± 15.78 0.5279 Total length (µm) 1199.76 ± 82.07 1212.78 ± 226.05 0.9574
Average ISI (ms) 51.11 ± 1.20 48.85 ± 0.43 0.0612 Complexity 88582.7 ± 415723.45 114749.12 ± 43933.76 0.5819
Ratio ISI1/ISIn 0.31 ± 0.02 0.33 ± 0.02 0.5513
Table 1. Electrophysiological and morphological comparison of L2/3 prelimbic pyramidal cells between SNI 
and sham treated mice. Values are mean ± SEM, with sample size in parenthesis. P-values were determined by 
Student’s t-test. x, y cell coordinates relative to the dorsal apex and midline of the coronal slice respectively, RMP 
resting membrane potential, τm membrane time constant, AP action potential, AHP after-hyperpolarization, dv/
dtmax peak depolarization velocity, dv/dtmin min peak repolarization velocity, ISI interspike interval, I-F input-
frequency; *p < 0.05.
Electrophysiology sham (n = 29) SNI (n = 27) P value Morphology sham (n = 10) SNI (n = 10) P value
RMP (mV) −67.29 ± 0.45 −68.06 ± 0.60 0.3072 Cell body
Input resistance (MΩ) 167.62 ± 13.76 179.50 ± 13.87 0.5464 x (µm) 933.61 ± 25.97 888.11 ± 26.34 0.2244
Membrane capacitance (pF) 193.56 ± 5.82 195.37 ± 6.25 0.8323 y (µm) 427.55 ± 6.98 425.96 ± 10.23 0.8972
τm (ms) 38.59 ± 2.71 42.51 ± 3.01 0.3350 Area (µm²) 131.81 ± 6.46 145.80 ± 7.61 0.1781
Sag ratio (%) 16.47 ± 1.63 14.99 ± 1.79 0.5431 Basal dendrites
Current threshold (pA) 114.83 ± 5.41 117.70 ± 4.95 0.6975 Number 3.60 ± 0.34 5.00 ± 0.39 *0.015
Voltage threshold (mV) −43.50 ± 0.52 −43.03 ± 0.57 0.5471 Nodes 3.70 ± 0.79 6.50 ± 1.77 0.1660
AP amplitude (mV) 57.84 ± 0.60 57.44 ± 0.64 0.6507 Ends 7.30 ± 0.92 11.60 ± 2.14 0.0809
dv/dtmax (mV/ms) 467.14 ± 16.17 471.62 ± 19.55 0.8599 Total length (µm) 463.68 ± 115.42 805.40 ± 163.92 0.1055
dv/dtmin (mV/ms) −63.21 ± 1.21 −64.65 ± 1.45 0.4471 Mean length (µm) 127.78 ± 27.35 150.67 ± 19.54 0.5045
AHP (mV) −48.88 ± 0.47 −48.56 ± 0.42 0.6178 Complexity 2880.24 ± 1455.72 5802.88 ± 2259.73 0.2913
AHP time to peak (ms) 5.04 ± 0.22 4.84 ± 0.17 0.4723 Apical dendrite
50% AP width (ms) 1.22 ± 0.02 1.18 ± 0.03 0.3547 Nodes 10.90 ± 1.62 12.70 ± 1.71 0.4545
I-F slope (Hz/100pA) 14.69 ± 0.35 13.47 ± 0.36 *0.0191 Ends 11.90 ± 1.62 13.90 ± 1.70 0.4063
1st AP latency (ms) 160.47 ± 11.41 173.42 ± 14.77 0.4872 Total length (µm) 1077.19 ± 122.03 1325.89 ± 160.00 0.2324
Average ISI (ms) 50.37 ± 0.25 50.51 ± 0.29 0.7206 Complexity 100610.14 ± 22502.23 152935.04 ± 44373.99 0.3069
Ratio ISI1/ISIn 0.39 ± 0.03 0.33 ± 0.03 0.1618
Table 2. Electrophysiological and morphological comparison of L5 prelimbic pyramidal cells between SNI 
and sham treated mice. Values are mean ± SEM, with sample size in parenthesis. P-values were determined by 
Student’s t test. x, y cell coordinates relative to the dorsal apex and midline of the coronal slice respectively, RMP 
resting membrane potential, τm membrane time constant, AP action potential, AHP after-hyperpolarization, 
dv/dtmax peak depolarization velocity, dv/dtmin min peak repolarization velocity, ISI interspike interval, I-F 
input-frequency; *p < 0.05.
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(Table 1). The firing pattern in both groups exhibited strong adaptation as indicated by the ratio of the first and last 
interspike interval obtained from the first trace with at least 10 APs (ISI1/ISIn: SNI 0.33 ± 0.02 vs. sham 0.31 ± 0.02; 
Student’s t-test, p > 0.05). The voltage sag ratio indicative for the activation of hyperpolarization-activated cyclic 
nucleotide–gated (HCN) channels in response to a hyperpolarizing current injection of ~−7.5 mV was similar 
in both groups (sham: 4.55 ± 0.25%; SNI: 4.27 ± 0.27%, Student’s t-test, p > 0.05) and consistent with low HCN 
channel expression in L2/3 pyramidal cells compared to deeper cortical layers38.
Anatomical reconstruction of 10 recorded pyramidal neurons per group showed no apparent differences in 
the length or complexity of basal and apical dendrites (Table 1). Furthermore, consistent with the unaltered mem-
brane capacitance (SNI 165.37 ± 8.12 pF vs. sham 171.89 ± 10.22 pF; Student’s t test, p > 0.05), there was no differ-
ence in the surface area of the somata between the two groups (SNI 102.10 ± 6.23 µm2 vs. sham 120.98 ± 9.65 µm2; 
Student’s t-test, p > 0.05). However, more detailed Sholl analysis41 revealed that basal dendrites of L2/3 pyramidal 
neurons from SNI treated mice had a higher number of intersections (Fig. 1g; 2-way ANOVA, treatment effect, 
p = 0.0059) and an increased length per distance compared to sham animals (Fig. 1g; 2-way ANOVA, treatment 
Figure 2. Firing rate and Sholl analysis of layer 5 pyramidal cells in the prelimbic (PrL) cortex of SNI and 
sham mice. (a) Location of recorded neurons in the hemisphere contralateral to the injured paw. Recordings 
were performed in the presence of blockers of fast synaptic transmission (5 µM CNQX, 5 µM D-AP5 and 
5 µM picrotoxin). Inset shows DAB stained, biocytin filled neurons in the targeted region. (b) Representative 
examples of reconstructed L5 PrL pyramidal cells. (c) Representative electrophysiological profile of L5 PrL 
pyramidal neurons in the SNI (left) and sham (right) group. Top, firing pattern when a minimum of 10 action 
potentials was elicited in response to the corresponding current step. Below, adaptation ratios from 1st to the 
n-1st interspike interval relative to the last (nth) presented as a heat map. Bottom, response to hyperpolarizing 
current injections to calculate input resistance and voltage sag ratio. (d) Bar graphs of the resting membrane 
potential and the input resistance of the two groups (p > 0.05, Student’s t-test). (e) Firing rate as a function of 
injected current showing a reduced discharge in SNI mice compared to sham controls (p < 0.05, 2-way ANOVA 
with repeated measures). Input-frequency slope calculated as a linear coefficient of the polynomial fitting of the 
curves (*p < 0.05, Student’s t-test). (f) Sholl analysis of reconstructed apical dendrites shows an increase in the 
number of intersections and length per distance from soma in SNI mice (p < 0.05, 2-way ANOVA). (g) Sholl 
analysis of the basal dendrites shows an increase in the number of intersections and length per distance from 
soma in SNI mice (p < 0.05, 2-way ANOVA).
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effect, p = 0.027). In contrast, in the apical dendrites the number of intersections and the dendritic length was 
similar between the two groups of mice (Fig. 1f; 2-way ANOVA, treatment effect, p > 0.05). Taken together, these 
findings suggest that neuropathic pain leads to a fine structural remodeling of the basal dendritic arbors of PrL 
L2/3 pyramidal neurons.
SNI reduces the firing rate of prelimbic layer 5 pyramidal neurons. We next tested if pyramidal 
neurons in L5, the main output layer of the neocortex, were altered in SNI treated mice 7 days after surgery. 
In recordings from PrL L5 pyramidal cells at the same relative coordinates in sham and SNI mice (Table 2; x/y 
coordinates: sham 933.61 ± 25.52/427.55 ± 6.86 µm vs. SNI 888.11 ± 25.85/425.96 ± 10.04 µm; Student’s t-test, 
px = 0.22/py = 0.90) we found no difference in passive membrane properties between the two treatment groups 
(Table 2; Fig. 2d). The resting membrane potential was −67.29 ± 0.45 mV for sham and −68.06 ± 0.58 mV 
for SNI (Student’s t-test, p = 0.31). Correspondingly, input resistance (SNI 179.50 ± 13.61 MΩ vs. sham 
167.62 ± 13.52 MΩ; Student’s t-test, p = 0.55) and AP parameters were similar in both groups (Table 2). Lower 
firing rates were detected in neurons of the SNI group in response to 500 ms depolarizing current injections 
(Fig. 2e; repeated measures 2-way ANOVA, treatment effect, p = 0.033). Consistently, the I-F linear slope was 
reduced in the SNI group following a polynomial fitting of the I-F relationship (SNI 13.47 ± 0.35 Hz/100 pA vs. 
sham 14.69 ± 0.35 Hz/100 pA; Student’s t test, p = 0.02). Overall, PrL L5 pyramidal neurons exhibited a promi-
nent and similar voltage sag of 16.47 ± 1.60% in sham and 14.99 ± 1.76% in SNI.
Even though none of the primary morphological parameters of the dendritic tree of L5 pyramidal cells dif-
fered between SNI and sham animals (Table 1), Sholl analysis revealed a significant increase in both apical and 
basal dendrites in the length per distance (2-way ANOVA, treatment effect: apical dendrites, p < 0.002; basal den-
drites, p < 0.001) as well as number of intersections (2-way ANOVA, treatment effect: apical dendrites, p < 0.001; 
basal dendrites, p < 0.001) in SNI mice (Fig. 2f,g).
SNI extends the dendritic arbor of infralimbic layer 2/3 pyramidal cells without altering their 
biophysical properties. In agreement with previous studies in mouse models of neuropathy our data 
indicate that the PrL cortex undergoes functional and morphological changes already 7 days after surgery42,43. 
However, we observed that the two subregions of the mPFC, namely the PrL and the IL, were robustly different 
in terms of their physiological parameters in the sham group, with the IL neurons of both L2/3 and L5 showing 
higher excitability as well as lower membrane capacitance (Supplemental Table 2). We recorded from L2/3 pyram-
idal neurons of the IL cortex that were equally distributed between the treatment groups (Table 3; x/y coordinates: 
sham 1679.26 ± 24.19/212.53 ± 5.32 µm vs. SNI 1646.73 ± 25.83/219.83 ± 5.53 µm; Student’s t-test, px = 0.39/
py = 0.37). In overt contrast to the PrL, both passive and active membrane properties of neurons were similar in 
SNI and control mice (Fig. 3d,e; Table 3). Conversely, morphological analysis revealed striking differences of IL 
L2/3 pyramidal cells between the two groups. Apical dendrites in SNI mice were significantly longer (Table 3; SNI: 
802.39 ± 68.37 µm vs. sham: 592.80 ± 60.66 µm; Student’s t-test, p = 0.04) and showed higher complexity (Table 3; 
SNI: 39338.6 ± 6253.1 vs. sham: 19301.0 ± 3938.2; Student’s t-test, p = 0.02). For the basal dendrites in the SNI 
group only a trend towards an increased length (SNI: 180.67 ± 30.39 µm vs. sham: 109.24 ± 12.84 µm; Student’s 
Electrophysiology sham (n = 16) SNI (n = 18) P value Morphology sham (n = 10) SNI (n = 10) P value
RMP (mV) −72.33 ± 1.44 −72.08 ± 1.47 0.9030 Cell body
Input resistance (MΩ) 241.38 ± 15.16 256.81 ± 16.94 0.5066 x (µm) 1679.26 ± 25.04 1646.73 ± 26.58 0.3865
Membrane capacitance (pF) 123.00 ± 5.10 130.42 ± 5.91 0.3543 y (µm) 212.53 ± 5.50 219.83 ± 5.69 0.3693
τm (ms) 42.79 ± 4.01 44.96 ± 2.59 0.6452 Area (µm²) 100.06 ± 11.42 102.13 ± 5.81 0.8736
Sag ratio (%) 3.92 ± 1.51 3.57 ± 1.27 0.8611 Basal dendrites
Current threshold (pA) 126.88 ± 9.95 119.17 ± 9.41 0.5775 Number 4.00 ±  ± 0.37 4.40 ± 0.31 0.4118
Voltage threshold (mV) −37.59 ± 0.61 −38.47 ± 0.66 0.3373 Nodes 5.60 ± 1.39 8.00 ± 1.42 0.2434
AP amplitude (mV) 57.32 ± 0.71 56.95 ± 0.85 0.7452 Ends 9.70 ± 1.71 12.60 ± 1.21 0.1829
dv/dtmax (mV/ms) 389.33 ± 17.72 412.03 ± 27.30 0.5023 Total length (µm) 464.57 ± 94.10 734.41 ± 97.31 0.0616
dv/dtmin (mV/ms) −58.53 ± 1.98 −58.73 ± 2.73 0.9538 Mean length (µm) 109.24 ± 13.54 180.67 ± 32.03 0.0548
AHP (mV) −48.28 ± 0.60 −47.51 ± 0.65 0.3962 Complexity 3491.24 ± 1169.46 9103.06 ± 2949.47 0.0939
AHP time to peak (ms) 5.12 ± 0.13 5.11 ± 0.18 0.9915 Apical dendrite
50% AP width (ms) 1.28 ± 0.03 1.30 ± 0.05 0.7528 Nodes 5.60 ± 0.70 8.60 ± 0.65 *0.0058
I-F slope (Hz/100pA) 15.58 ± 0.66 15.46 ± 1.04 0.9248 Ends 6.60 ± 0.70 9.60 ± 0.65 *0.0058
1st AP latency (ms) 223.30 ± 25.92 208.74 ± 19.90 0.6550 Total length (µm) 592.80 ± 63.95 802.39 ± 72.07 *0.0432
Average ISI (ms) 50.46 ± 0.44 50.88 ± 0.45 0.5104 Complexity 19301.08 ± 4151.24 39338.68 ± 6591.43 *0.0192
Ratio ISI1/ISIn 0.37 ± 0.02 0.32 ± 0.02 0.0961
Table 3. Electrophysiological and morphological comparison of L2/3 infralimbic pyramidal cells between SNI 
and sham treated mice. Values are mean ± SEM, with sample size in parenthesis. P-values were determined by 
Student’s t-test. x, y cell coordinates relative to the dorsal apex and midline of the coronal slice respectively, RMP 
resting membrane potential, τm membrane time constant, AP action potential, AHP after-hyperpolarization, 
dv/dtmax peak depolarization velocity, dv/dtmin min peak repolarization velocity, ISI interspike interval, I-F 
input-frequency; *p < 0.05.
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t-test, p = 0.055) and complexity (SNI: 9103.0 ± 2798.1 vs. sham: 3491.2 ± 1109.4; Student’s t-test, p = 0.09) was 
observed. Consistently, Sholl analysis revealed a higher number of intersections (2-way ANOVA, treatment effect: 
apical dendrites, p < 0.001; basal dendrites, p < 0.001) and increased length (2-way ANOVA, treatment effect: 
apical dendrites, p < 0.001; basal dendrites, p = 0.002) of both the apical and basal dendrites compared to sham 
(Fig. 3f,g).
SNI does not affect the morphological and physiological features of infralimbic layer 5 pyramidal 
cells. Finally, we tested L5 pyramidal cells of the IL cortex (Table 4; x/y coordinates: sham 1679.26 ± 24.19/
212.53 ± 5.32 µm vs. SNI 1646.73 ± 25.83/219.83 ± 5.53 µm; Student’s t-test, px = 0.39/py = 0.37). Resting mem-
brane potential (SNI: −66.91 ± 0.63 mV vs. sham: −66.31 ± 0.64 mV; Student’s t-test, p = 0.44) and input resist-
ance (sham: 179.77 ± 10.98 MΩ vs. SNI: 188.70 ± 6.92 MΩ; Student’s t-test, p = 0.49) were similar in both groups 
(Fig. 4d). SNI surgery did not alter the AP firing rate (Fig. 4e; repeated measures 2-way ANOVA, p > 0.05) or any 
of the additional AP parameters (Table 4).
Figure 3. Firing rate and Sholl analysis of layer 2/3 pyramidal cells in the infralimbic (IL) cortex of SNI and 
sham mice. (a) Location of recorded neurons in the hemisphere contralateral to the injured paw. Recordings 
were performed in the presence of blockers of fast synaptic transmission (5 µM CNQX, 5 µM D-AP5 and 
5 µM picrotoxin). Inset shows DAB stained, biocytin filled neurons in the targeted region. (b) Representative 
examples of L2/3 IL pyramidal cells. (c) Representative electrophysiological profile of L2/3 IL pyramidal 
neurons in the SNI (left) and sham (right) group. Top, firing pattern when a minimum of 10 action potentials 
was elicited in response to the corresponding current step. Underneath, adaptation ratios from 1st to the n-1st 
interspike interval relative to the last (nth) presented as a heat map. Bottom, response to hyperpolarizing current 
injections to calculate the input resistance and the voltage sag ratio. (d) Column graphs showing the resting 
membrane potential and input resistance of the two groups (p > 0.05, Student’s t-test). (e) Firing rate as a 
function of injected current in SNI mice compared to sham controls (p > 0.05, 2-way ANOVA with repeated 
measures). Input-frequency slope calculated as a linear coefficient of the polynomial fitting of the curves 
(p > 0.05, Student’s t-test). (f) Sholl analysis of the reconstructed apical dendrites shows an increase in the 
number of intersections and length per distance from soma in SNI mice (p < 0.05, 2-way ANOVA). (g) Sholl 
analysis of basal dendrites shows an increase in the number of intersections and length per distance from soma 
in SNI mice (p < 0.05, 2-way ANOVA).
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Correspondingly, the morphology of the apical and basal dendrites of L5 cells was similar between SNI and 
sham treated mice (Table 4). Sholl analysis, likewise, showed similar numbers of intersections (2-way ANOVA, 
p > 0.05) and branching (2-way ANOVA, p > 0.05) in both apical and basal dendrites of L5 pyramidal neurons of 
the two groups (Fig. 4f,g).
Discussion
In the current study, we used a combined electrophysiological and morphological approach to assess altera-
tions of mPFC pyramidal neurons induced by neuropathic nerve injury with a special focus on subregional 
and laminar specificity. We report a differential modulation of neuronal excitability in L2/3 and L5 of the PrL 
following SNI. In contrast, IL pyramidal cells were functionally unaltered in all layers investigated. Anatomical 
reconstruction of the recorded neurons showed that neuropathic pain was associated with increased dendritic 
length and complexity of pyramidal cells in L2/3 of the IL. Limited structural rearrangements were also revealed 
in L2/3 and L5 neurons of the PrL that were, however, only detected by more detailed analysis of their morpho-
logical characteristics.
Our results build on previous studies showing that stimulation of deeper layers of the mPFC alleviates both 
the sensory and affective components of pain and that their inhibition worsens nocifensive and motivational 
behaviour13,43–47. Specifically, we found that PrL L2/3 pyramidal neurons showed an increased input resistance 
and a more depolarized resting membrane potential 7 days after SNI treatment, indicative of increased excit-
ability. These findings are in line with Cordeiro Matos, et al.32 reporting higher input resistance and neuronal 
activity in superficial layers of the mPFC of SNI treated rats three weeks after surgery. Persistent pain in SNI 
treated rats 7 days after surgery is associated with increased synaptic signalling in L2/3 pyramidal neurons due to 
an increase in the NMDA/AMPA ratio15. Moreover, overexpression of the NMDA receptor subunit NR2B in the 
mPFC increases responsiveness to inflammatory stimuli48.
However, SNI induced effects on passive and active membrane properties of L2/3 pyramidal cells are contro-
versial and this may be related to pooling neuronal recordings from different neighbouring regions that show 
small but important differences, such as more dorsal regions corresponding to ACC rather than PrL15,30,32.
In contrast to pyramidal cells in the superficial PrL cortex, deep PrL L5 pyramidal neurons of SNI mice gen-
erated significantly lower firing rates in response to suprathreshold depolarizing current injections compared 
to controls. This is in line with previous studies reporting reduced excitability and action potential discharge 
activity of L5 PrL neurons within the mPFC in the SNI model of neuropathic pain42,43. A possible explanation for 
functional deactivation of the PrL cortex in neuropathic pain could be a reduction in glutamatergic currents in 
L5 pyramidal neurons of the mPFC of SNI rats30. More likely, local or amygdala driven feed-forward inhibition 
may account for neuron deactivation as documented in rat models of arthritis and SNI43. These in vitro data are 
corroborated by an in vivo study demonstrating reduced basal spontaneous as well as pain-evoked activity in the 
PrL in a rat model of persistent inflammatory pain49.
We also observed important differential effects of SNI on pyramidal cell excitability between the PrL and IL 
cortical regions (Supplemental Table 2). This could be explained by differential inputs that PrL and IL cortices 
receive from subcortical areas, in particular the basolateral amygdala50, which is reflected by the different roles of 
Electrophysiology sham (n = 24) SNI (n = 29) P value Morphology sham (n = 10) SNI (n = 10) P value
RMP (mV) −66.31 ± 0.65 −66.91 ± 0.44 0.4360 Cell body
Input resistance (MΩ) 179.77 ± 11.22 188.70 ± 7.04 0.4890 x (µm) 1699.43 ± 19.61 1671.66 ± 16.54 0.2807
Membrane capacitance (pF) 147.90 ± 5.81 138.11 ± 4.05 0.1625 y (µm) 408.38 ± 6.00 412.52 ± 6.78 0.6559
τm (ms) 36.87 ± 1.71 35.30 ± 1.48 0.4881 Area (µm²) 126.43 ± 6.87 124.18 ± 3.97 0.7798
Sag ratio (%) 19.58 ± 1.49 19.68 ± 0.01 0.9559 Basal dendrites
Current threshold (pA) 95.83 ± 4.58 93.79 ± 3.95 0.7360 Number 4.80 ± 0.33 3.90 ± 0.23 *0.0378
Voltage threshold (mV) −41.33 ± 0.32 −41.95 ± 0.40 0.2486 Nodes 4.70 ± 1.01 3.10 ± 0.80 0.2296
AP amplitude (mV) 59.91 ± 0.45 59.35 ± 0.58 0.4672 Ends 9.60 ± 1.23 7.10 ± 0.81 0.1069
dv/dtmax (mV/ms) 526.34 ± 17.36 515.66 ± 15.16 0.6436 Total length (µm) 573.49 ± 89.81 476.44 ± 111.45 0.5064
dv/dtmin (mV/ms) −61.84 ± 1.20 −61.29 ± 1.02 0.7276 Mean length (µm) 117.87 ± 13.30 129.35 ± 33.32 0.7526
AHP (mV) −48.43 ± 0.38 −48.72 ± 0.47 0.6355 Complexity 2844.34 ± 799.60 2744.65 ± 1012.92 0.9393
AHP time to peak (ms) 4.61 ± 0.08 4.79 ± 0.11 0.1955 Apical dendrite
50% AP width (ms) 1.21 ± 0.02 1.24 ± 0.02 0.2802 Nodes 10.10 ± 1.16 9.80 ± 1.81 0.8904
I-F slope (Hz/100pA) 15.83 ± 0.70 15.62 ± 0.49 0.7998 Ends 11.40 ± 1.11 11.00 ± 1.78 0.8510
1st AP latency (ms) 142.67 ± 10.18 134.66 ± 8.85 0.5539 Total length (µm) 1093.56 ± 139.81 1119.48 ± 165.38 0.9060
Average ISI (ms) 49.84 ± 0.40 49.32 ± 0.40 0.3761 Complexity 91471.94 ± 28581.70 102676.71 ± 34763.74 0.8062
Ratio ISI1/ISIn 0.34 ± 0.02 0.32 ± 0.02 0.3738
Table 4. Electrophysiological and morphological comparison of L5 infralimbic pyramidal cells between SNI 
and sham treated mice. Values are mean ± SEM, with sample size in parenthesis. P-values were determined by 
Student’s t test. x, y cell coordinates relative to the dorsal apex and midline of the coronal slice respectively, RMP 
resting membrane potential, τm membrane time constant, AP action potential, AHP after-hyperpolarization, 
dv/dtmax peak depolarization velocity, dv/dtmin min peak repolarization velocity, ISI interspike interval, I-F 
input-frequency; *p < 0.05.
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these areas in fear learning and memory51–53. Previous studies mainly focused on the ACC and the PrL cortices, 
since experimental lesions within these areas reduced mechanical hypersensitivity as well as conditioned-place 
aversion, whereas lesions of the IL cortex did not54,55.
So far, electrophysiological studies investigating the role of IL cortex in pain processing have not been con-
clusive. We demonstrate that functional properties of pyramidal cells in both superficial and deep cortical layers 
in the IL cortex are unaltered in neuropathic mice, which is in line with Cheriyan and Sheets42. Other studies, 
however, report changes in the IL, including loss of parvalbumin expressing (PV+) neurons and reduction of axon 
initial segment length in L5/6 neurons of the IL but not PrL three weeks after SNI injury56.
Apart from functional changes, pyramidal cells in superficial layers of the mPFC were shown to undergo 
morphological structural changes following SNI15. Our findings are consistent with this report, also demonstrat-
ing increased dendritic branching only in the basal but not the apical dendrites of PrL L2/3 pyramidal cells in 
SNI mice. In addition, the apical and basal dendrites of L5 PrL pyramidal cells showed a moderately increased 
branching after SNI, but no significant changes in total dendritic length and complexity. These findings appear at 
odds with a recent study reporting reduced length and branching of apical dendrites, along with reduced glutama-
tergic currents, in the mPFC of SNI rats30. Kelly, et al.30 also reported an increased input resistance and a reduced 
Figure 4. Firing rate and Sholl analysis of layer 5 pyramidal cells in the infralimbic (IL) cortex of SNI and 
sham mice. (a) Location of recorded neurons in the hemisphere contralateral to the injured paw. Recordings 
were performed in the presence of blockers of fast synaptic transmission (5 µM CNQX, 5 µM D-AP5 and 
5 µM picrotoxin). Inset shows DAB stained, biocytin filled neurons in the targeted region. (b) Representative 
examples of L5 IL pyramidal cells. (c) Representative electrophysiological profile of L5 IL pyramidal neurons in 
the SNI (left) and sham (right) group. Top, firing pattern when a minimum of 10 action potentials was elicited 
in response to the corresponding current step. Below, adaptation ratios from 1st to the n-1st interspike interval 
relative to the last (nth) presented as a heat map. Bottom, response to hyperpolarizing current injections to 
calculate input resistance and voltage sag ratio. (d) Column graphs showing the resting membrane potential 
and input resistance of the two groups (p > 0.05, Student’s t-test). (e) Comparable firing rate as a function of 
injected current between the two groups (p > 0.05, 2-way ANOVA with repeated measures). Input-frequency 
slope calculated as a linear coefficient of the polynomial fitting of the curves (p > 0.05, Student’s t-test). (f,g) 
Sholl analysis of the reconstructed apical and basal dendrites in SNI and sham treated mice (p > 0.05, 2-way 
ANOVA).
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membrane capacitance of these cells that we could not observe in our experiments. Although species-specific 
differences cannot be ruled out, the reasons for this discrepancy are at present unclear and warrant further 
investigations.
Pyramidal neurons in deeper cortical layers of the IL were morphologically unaltered by SNI 7 days after sur-
gery. This supports our electrophysiological data, as we observed no difference in the excitability of the recorded 
neurons in this layer. However, superficial pyramidal cells of the IL showed increased dendritic branching at both 
basal and the apical dendrites. With L2/3 representing the main mPFC input region, this increased dendritic 
complexity could represent a compensatory mechanism in response to a reduced glutamatergic input from the 
ventral hippocampus and mediodorsal thalamus57. That neuropathic pain leads to changes in dendritic branching 
correlates well with the upregulation of genes important for axonal guidance and maturation of dendritic spines, 
observed in the mPFC of SNI mice58.
The reasons for subregion- and layer-specific changes can be manifold. One possibility may be alterations in 
the activity of different local inhibitory circuits. Different GABAergic interneuron types differ in how they syn-
apse on projection neurons, and thereby in how they control excitability and action potential integration before 
an output is generated59. They are distributed in a specific manner across different cortical layers60. For example, 
somatostatin (SOM+) and PV+ interneurons in L5 of the somatosensory cortex show reduced activity in the SNI 
mouse model, whereas vasointestinal polypeptide-expressing (VIP+) interneurons exhibit increased activity61. 
Consistently, the activity of PV+ interneurons drives the increase in the inhibitory GABAergic tone in PrL L5 of 
SNI operated mice43, while the excitation profile of PrL L2/3 PV+ interneurons and SOM+ interneurons across 
both layers is unaltered in the chronic constriction injury mouse model42.
Alternatively, altered input to the mPFC may be sufficient to explain the subregion- and layer-specific differ-
ences. Terminals from the ventral hippocampus are distributed unevenly in the mPFC, with more terminals end-
ing in ventral regions57, and the basolateral amygdala (BLA) projecting to layer 2 neurons of the PrL rather than 
the IL50. Interestingly, BLA projections preferentially target neurons projecting to the periaquaeductal grey, the 
main descending pain control hub50. This top-down control of the descending pain-pathway has also been impli-
cated as a possible target contributing to the chronification of pain, with facilitation of either direct ACC-to-spinal 
cord62 or sensory cortex-to-spinal cord63 projections. Therefore, modulation of specific types of interneurons 
limited to specific mPFC subregions and layer specific projections from relevant pain processing brain regions 
could be responsible for the currently observed differences.
Also, it should be noted that the changed electrophysiological and morphological properties observed in the 
different layers and subregions of the mPFC might vary between different timepoints after nerve injury, and 
might therefore be associated with different stages of neuropathy and pain chronification.
Studies on humans and rodents strongly suggest that males and females show different sensitivity to pain and 
differences in peripheral or spinal processing of painful stimuli64,65. Women show stronger activation of the mPFC 
than men in response to subthreshold and strong painful stimuli, which could be linked to increased self-related 
attention in response to pain66 and only female mice show differential pERK activation in mPFC in a partial nerve 
ligation model67. In the current investigation all recordings were performed in male mice since male SNI mice are 
significantly more impaired in a set-shifting task for prefrontal cortex dysfunction than female mice56. However, 
additional studies are required to obtain mechanistic insight into sex-specific circuits for the processing of noci-
ceptive stimuli in the mPFC.
In the present study we provide the first systematic investigation of subregion and layer specific neuronal 
changes occurring in the PrL and IL cortices of neuropathic mice, thereby providing new insights into mPFC 
neuronal reorganization associated with the chronification of pain.
In conclusion, our results support the view that neuropathic pain results from region- and layer-specific func-
tional as well as structural changes of the mPFC. The dissection of these complex alterations may contribute to 
a better understanding of the widespread plasticity events occurring in different brain regions as a consequence 
of long-lasting pain, and possibly to the identification of novel strategies for the development of more effective, 
mechanism-targeted treatments.
Data Availability
The datasets generated during and/or analyzed during the current study are available from the corresponding 
author on reasonable request.
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